STAT February 23, 2024
Hello! Today, we discuss how the FDA is holding firm in how it handles non-compliant trial sponsors and investigators, how PhRMA is rebuilding its ranks, and offer up a fabulous podcast.
The need-to-know this morning
- Advisers to the European Medicines Agency recommended the approval of Qalsody, a treatment for ALS from Biogen.
What do CEOs owe the world?
Did Humira break the system? And can you CRISPR a fetus? We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast.
First, former Alnylam Pharmaceuticals CEO John Maraganore and STAT’s Matthew Herper join us to discuss the legacy of AbbVie chief executive Richard Gonzalez, who announced his retirement this week. Then, we dive into the...
Today's Sponsors
Today's Sponsor
